TNF and COVID-19: The platform of hiPSC-CMs has been used as an in vitro SARS-CoV-2 infection model to determine the inflammatory process involved in the ability of TNF-α to exacerbate the cytokine storm and aggravate myocardial damage in patients with COVID-19 [11].